1. Reversal of Overanticoagulation in Very Elderly Hospitalized Patients with an INR above 5.0: 24-Hour INR Response after Vitamin K Administration 
Eric Pautas, MD, PhD, Isabelle Peyron, PharmD, Samir Bouhadiba, PharmD, Jean-Louis Golmard, MD, PhD, Adeline Gouronnec, MD, Nadine Oboa, PharmD, Virginie Siguret, PhD, Isabelle Gouin-Thibault, PhD 
The American Journal of Medicine 
Volume 124, Issue 6, Pages (June 2011)
DOI: /j.amjmed
Copyright © 2011 Elsevier Inc. Terms and Conditions

2. Figure 1 Distribution of concomitant medications (number/patient).
The American Journal of Medicine  , DOI: ( /j.amjmed )
Copyright © 2011 Elsevier Inc. Terms and Conditions

3. Figure 2
Day 0 and Day 1 international normalized ratios (INRs), and P values for the difference:
(A) 217 Day 0 INRs managed according to recommendations.
(B) 121 Day 0 INRs between 5.0 and 6.0 managed with VKA dose omission and vitamin K1 administration according to recommendations.
(C) 48 Day 0 INRs between 5.0 and 6.0 managed with VKA dose omission but no vitamin K1 administration.
The therapeutic range is represented by the rectangle.
The American Journal of Medicine  , DOI: ( /j.amjmed )
Copyright © 2011 Elsevier Inc. Terms and Conditions